1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
oa
The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women
Rent:
Rent this article for
Access full text Article
/content/aip/journal/adva/2/1/10.1063/1.3699052
1.
1. A. Johnson and J. Shekhdar, Journal of Evaluation in Clinical Practice 11, 21 (2005).
http://dx.doi.org/10.1111/j.1365-2753.2004.00487.x
2.
2. J. Mandelblatt, M. Figueiredo, and J. Cullen, Health and Quality of Life Outcomes 1, 45 (2003).
http://dx.doi.org/10.1186/1477-7525-1-45
3.
3. S. J. London, J. L. Connolly, S. J. Schnitt, and G. A. Golditz, The Journal of the American Medical Association 267, 941 (1992).
http://dx.doi.org/10.1001/jama.1992.03480070057030
4.
4. E. Anderson, S. C. Reed, R. A. Huseby, and C. P. Oliver, Cancer 3, 410 (1950).
http://dx.doi.org/10.1002/1097-0142(1950)3:3<410::AID-CNCR2820030303>3.0.CO;2-H
5.
5. R. B. Wallace, B. M. Sherman, J. A. Bean, J. P. Leeper, and A. E. Treloar, Cancer Research 38, 4021 (1978).
6.
6. H. Fredholm, S. Eaker, J. Frisell, L. Holmberg, I. Fredriksson, and H. Lindman, PLoS ONE 4, e7695 (2009).
http://dx.doi.org/10.1371/journal.pone.0007695
7.
7. D. Flesch-Janys, T. Slanger, E. Mutschelknauss, S. Kropp, N. Obi, E. Vettorazzi, W. Braendle, G. Bastert, S. Hentschel, J. Berger, and J. Chang-Claude, International Journal of Cancer 123, 933 (2008).
http://dx.doi.org/10.1002/ijc.23655
8.
8. K. Takahashi, M. Ohmichi, M. Yoshida, K. Hisamoto, S. Mabuchi, E. Arimoto-Ishida, A. Mori, A. Tsutsumi, K. Tasaka, Y. Murata, and H. Kurachi, Journal of Endocrinology 178, 319 (2003).
http://dx.doi.org/10.1677/joe.0.1780319
9.
9. P. Kastner, A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gronemeyer, and P. Chambon, European Molecular Biology Organization Journal 9, 1603 (1990).
10.
10. J. D. Graham and C. L. Clarke, Endocrine Reviews 18, 502 (1997).
http://dx.doi.org/10.1210/er.18.4.502
11.
11. D. X. Wen, Y.-F. Xu, Dale E. Mais, Mark E. Goldman, and Donald P. McDonnell, Molecular and Cellular Biology 14, 8356 (1994).
12.
12. A. Albert, R. V. Randall, and R. A. Smith, Hormones and the Aging Process (Academic Press, Inc., New York, 1956).
13.
13. R. T. Chlebowski, L. H. Kuller, R. L. Prentice, M. L. Stefanick, J. E. Manson, M. Gass, A. K. Aragaki, J. K. Ockene, D. S. Lane, G. E. Sarto, A. Rajkovic, R. Schenken, S. L. Hendrix, P. M. Ravdin, T. E. Rohan, S. Yasmeen, and G. Anderson, The New England Journal of Medicine 360, 573 (2009).
http://dx.doi.org/10.1056/NEJMoa0807684
14.
14. P. E. Goss, J. N. Ingle, S. Martino, N. Robert, H. B. Muss, M. J. Piccart, M. Castiglione, D. Tu, L. E. Shepherd, K. I. Pritchard, R. B. Livingston, N. E. Davidson, L. Norton, E. A. Perez, J. S. Abrams, D. A. Cameron, M. J. Palmer, and J. L. Pater, Journal of the National Cancer Institute 97, 1267 (2005).
http://dx.doi.org/10.1093/jnci/dji250
15.
15. J. Cuzick, I. Sestak, M. Baum, A. Buzdar, A. Howell, M. Dowsett, and J. F. Forbes, Lancet Oncol. 11, 1135 (2010).
http://dx.doi.org/10.1016/S1470-2045(10)70257-6
16.
16. C. Kim, G. Tang, K. L. Pogue-Geile, J. P. Costantino, F. L. Baehner, J. Baker, M. T. Cronin, D. Watson, S. Shak, O. L. Bohn, D. Fumagalli, Y. Taniyama, A. Lee, M. L. Reilly, V. G. Vogel, W. McCaskill-Stevens, L. G. Ford, C. E. Geyer Jr., D. L. Wickerham, N. Wolmark, and S. Paik, Journal of Clinical Oncology 29, 4160 (2011).
http://dx.doi.org/10.1200/JCO.2010.32.9615
17.
17. C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover, The Journal of the American Medical Association 283, 485 (2000).
http://dx.doi.org/10.1001/jama.283.4.485
18.
18. Writing Group for the Women's Health Initiative Investigator, The Journal of the American Medical Association 288, 321 (2002) and references within.
http://dx.doi.org/10.1001/jama.288.3.321
19.
19. B. Katzenellenbogen, I. Choi, R. Delage-Mourroux, T. R. Ediger, P. G. V. Martini, M. Montano, J. Sun, K. Weis, and J. A. Katzenellenbogen, Journal of Steroid Biochemistry and Molecular Biology 74, 279 (2000).
http://dx.doi.org/10.1016/S0960-0760(00)00104-7
20.
20. P. Webb, P. Nguyen, and P. J. Kushner, J. Biol. Chem. 278, 6912 (2003).
http://dx.doi.org/10.1074/jbc.M208501200
21.
21. M. Dutertre and C. L. Smith, The Journal of Pharmacology and Experimental Therapeutics 295, 431 (2000).
22.
22. A. Goldhirsch, J. H. Glick, R. D. Gelber, and H.-J. Senn, Journal of the National Cancer Institute 90, 1601 (1998).
http://dx.doi.org/10.1093/jnci/90.21.1601
23.
23. L. A. Emens and N. E. Davidson, Clinical Cancer Research 9, 280s (2003).
24.
24. I. Wiklund, J. Karlberg, and L. A. Mattsson, American Journal of Obstetrics and Gynecology 168, 824 (1993).
25.
25. J. N. Ingle, Breast Cancer Research 4, 133 (2002).
http://dx.doi.org/10.1186/bcr436
26.
26. T. S. Wiley and B. Formby, Molecular Cell Biology 202, 53 (1999).
http://dx.doi.org/10.1023/A:1007081021483
27.
27. S. Formenti, J. Felix, D. Salonga, K. Danenberg, M. C. Pike, and P. Danenberg, Clinical Cancer Research 6, 4653 (2000).
28.
28. J. Boney-Montoya, Y. S. Ziegler, C. D. Curtis, Jonathan A. Montoya, and A. M. Nardulli, Molecular Endocrinology 21, 439 (2010).
29.
29. M. Guray and A. A. Sahin, The Oncologist 11, 435 (2006).
http://dx.doi.org/10.1634/theoncologist.11-5-435
30.
30. R. J. Santen and G. R. Petroni, The Journal of Clinical Endocrinology and Metabolism 84, 1875 (1999).
http://dx.doi.org/10.1210/jc.84.6.1875
31.
31. A. Fazzari, M. G. Catalano, A. Comba, M. Becchis, M. Raineri, R. Frairia, and N. Fortunati, Molecular and Cellular Endocrinology 172, 31 (2001).
http://dx.doi.org/10.1016/S0303-7207(00)00397-X
32.
32. V. C. Jordan and L. G. Ford, Cancer Prevention Research 10, 1158 (2011).
33.
33. R. Ramakrishnan, S. A. Khan, and S. Badve, Modern Pathology 12, 1348 (2002).
http://dx.doi.org/10.1097/01.MP.0000039566.20817.46
34.
34. O. M. Conneely, B. Mulac-Jericevic, J. P. Lydon, and F. J. De Mayo, Molecular and Cellular Endocrinology 179, (2001).
http://dx.doi.org/10.1016/S0303-7207(01)00465-8
35.
35. M.-E. Meyer, C. Quirin-Stricker, T. Lerouge, M.-T. Bocquel, and H. Gronemeyer, The Journal of Biological Chemistry 267, 10882 (1992).
36.
36. E. B. Claus, N. J. Risch, and W. D. Thompson, American Journal of Epidemiology 131, 961 (1990).
37.
37. J. Gauduchon, F. Guilleux, S. Maillard, V. Marsaud, M. Renoir, and B. Sola, Annals of New York Academy of Sciences 1010, 321 (2003).
http://dx.doi.org/10.1196/annals.1299.057
38.
38. E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling, Pharmacological Reviews 52, 513 (2000).
39.
39. S. L. Lightman, C. C. Wiles, H. C. Atkinson, D. E. Henley, G. M. Russell, J. A. Leendertz, M. A. McKenna, F. Spiga, S. A. Wood, and B. L. Conway-Campbell, European Journal of Pharmacology 583, 255 (2008).
http://dx.doi.org/10.1016/j.ejphar.2007.11.073
40.
40. E. Norjavaara, C. Ankarberg, and K. Albertsson-Wikland, Journal of Clinical Endocrinology and Metabolism 81, 4095 (1996).
http://dx.doi.org/10.1210/jc.81.11.4095
41.
41. X. Gao, B. W. Loggie, and Z. Nawaz, Molecular Cancer 1, 1186 (2002).
http://dx.doi.org/10.1186/1476-4598-1-7
42.
42. J. Taguchi, Unpublished work and private communications.
43.
43. J. Williams, Unpublished work.
http://aip.metastore.ingenta.com/content/aip/journal/adva/2/1/10.1063/1.3699052
Loading
/content/aip/journal/adva/2/1/10.1063/1.3699052
Loading

Data & Media loading...

Loading

Article metrics loading...

/content/aip/journal/adva/2/1/10.1063/1.3699052
2012-03-29
2014-07-29

Abstract

We present a theory that questions the standard of care for pre- and post-menopausal women with breast cancer. Through the use of modulated hormones to mimic the natural multiphasic fluctuations of estrogen and progesterone cycles of healthy young women, it can be expected that patients will not only exhibit increased quality of life such as better sleep, well-being, and libido, but also memory improvement and less joint pain. Additionally, this regimen may engage genetic pathways that protect women in youth from breast cancers. We present a mathematical basis for the coupling of the hormone cycles through the use of Gaussian curves that provides the foundation of a new format of hormone replacement in women.

Loading

Full text loading...

/deliver/fulltext/aip/journal/adva/2/1/1.3699052.html;jsessionid=tbicb0onfu2u.x-aip-live-06?itemId=/content/aip/journal/adva/2/1/10.1063/1.3699052&mimeType=html&fmt=ahah&containerItemId=content/aip/journal/adva
true
true
This is a required field
Please enter a valid email address
This feature is disabled while Scitation upgrades its access control system.
This feature is disabled while Scitation upgrades its access control system.
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women
http://aip.metastore.ingenta.com/content/aip/journal/adva/2/1/10.1063/1.3699052
10.1063/1.3699052
SEARCH_EXPAND_ITEM